Kristina Jankovic/X
Jan 6, 2025, 14:27
Kristina Jankovic: Oncology leads the way
Kristina Jankovic, Medical Oncology Resident at the University Clinical Center Niš, shared a recent article by Asher Mullard on X:
“Oncology leads the way.
In 2024, the FDA approved 50 new therapies, with 15 (30%) targeting cancer – including multiple first-in-class therapies and the 11th PD1/PDL1 inhibitor.”
Author: Asher Mullard
Kristina Jankovic, MD, is a Medical Oncology Resident at the University Clinical Center Niš, where she works at the Oncology Clinic. Her primary interests include breast cancer, innovative cancer therapies, oncofertility, and hereditary cancers. She is a member of ESMO, ASCO, and the European School of Oncology (ESO).
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 6, 2025, 14:27
Jan 6, 2025, 14:24
Jan 6, 2025, 13:02
Jan 6, 2025, 12:59
Jan 6, 2025, 12:33
Jan 6, 2025, 12:31
Jan 6, 2025, 12:31